Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients
暂无分享,去创建一个
G. Bastert | M. Feuerer | L. Bai | I. Diel | E. Solomayer | V. Schirrmacher | M. Rocha | V. Umansky
[1] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[2] Henrique Veiga-Fernandes,et al. Response of naïve and memory CD8+ T cells to antigen stimulation in vivo , 2000, Nature Immunology.
[3] D. Speiser,et al. Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression1 , 2000, The Journal of Immunology.
[4] R. Coombes,et al. Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study , 1999, The Lancet.
[5] R. Cote,et al. Detection and clinical importance of micrometastatic disease. , 1999, Journal of the National Cancer Institute.
[6] K. Pantel,et al. Hunting down the seminal cells of clinical metastases. , 1999, Immunology today.
[7] P. Crocker,et al. Sialoadhesin-positive host macrophages play an essential role in graft-versus-leukemia reactivity in mice. , 1999, Blood.
[8] Paul W Price,et al. Characterization of CD4+ T cells in mouse bone marrow. I. Increased activated/memory phenotype and altered TCR Vβ repertoire , 1999, European journal of immunology.
[9] J. Sogn. Tumor immunology: the glass is half full. , 1998, Immunity.
[10] F. Gounari,et al. EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells. , 1998, Cancer research.
[11] S. Braun,et al. Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. , 1996, Journal of the National Cancer Institute.
[12] S. Rutella,et al. Flow cytometric detection of perforin in normal human lymphocyte subpopulations defined by expression of activation/differentiation antigens. , 1998, Immunology letters.
[13] R. Ahmed,et al. Bone marrow contains virus-specific cytotoxic T lymphocytes. , 1997, Blood.
[14] M. Cooper,et al. Memory B lymphocytes migrate to bone marrow in humans. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Cheever,et al. HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer. , 1997, Advances in cancer research.
[16] A. Kessinger,et al. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood. , 1996, Bone marrow transplantation.
[17] R. Holle,et al. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. , 1996, Journal of the National Cancer Institute.
[18] N. Shastri,et al. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. , 1995, Immunity.
[19] I. Weissman,et al. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells. , 1995, Blood.
[20] D. Longo,et al. Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor. , 1995, Journal of the National Cancer Institute.
[21] J. Wharton,et al. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines , 1995, The Journal of experimental medicine.
[22] A. Dickinson,et al. Cytokine treatment of human bone marrow activates anti-leukaemia effector cells: monitoring of purging by polymerase chain reaction and DNA analysis. , 1995, Leukemia.
[23] R. Negrin,et al. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. , 1994, Journal of immunology.
[24] S. Russell,et al. Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Huhn,et al. Propagation of large numbers of T cells with natural killer cell markers , 1994, British journal of haematology.
[26] J. Sprent. T and B memory cells , 1994, Cell.
[27] T. Springer. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.
[28] B. Gückel,et al. Tumour‐Specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens , 1993, Immunology and cell biology.
[29] S. Crowe,et al. Bacterial lipopolysaccharide mediates the loss of CD4 from the surface of purified peripheral blood monocytes , 1992, Clinical and experimental immunology.
[30] A. McLean,et al. Lifespan of human lymphocyte subsets defined by CD45 isoforms , 1992, Nature.
[31] H. Warren,et al. Loss of activation-induced CD45RO with maintenance of CD45RA expression during prolonged culture of T cells and NK cells. , 1991, Immunology.
[32] F. Miedema,et al. Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation. , 1991, Journal of immunology.
[33] P Clark,et al. Lymphocyte subsets in normal bone marrow. , 1986, Blood.